Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases - DAPT Duration According the Bleeding Risk

NCT05631769 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05631769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05631769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases - DAPT Duration According the Bleeding Risk
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
July 24, 2020
Completion date
December 31, 2027
Enrollment
4,900 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, coronary artery disease, stable angina